OU, L. Et Al. 2020. Long-Term Safety and Efficacy of the PS Gene Editing System forMucopolysaccharidosis Type I. ASGCT 23rd Annual Meeting , 1-592.

OU, L., PRZYBILLA, M., AHLAT, O., OVERN, P., O SULLIVAN, G., KIM, S., ... JARNES, J.(2020). Long-Term Safety and Efficacy of the PS Gene Editing System forMucopolysaccharidosis Type I . ASGCT 23rd Annual Meeting (pp.1-592).

OU, LI Et Al. "Long-Term Safety and Efficacy of the PS Gene Editing System forMucopolysaccharidosis Type I," ASGCT 23rd Annual Meeting, 2020

OU, LI Et Al. "Long-Term Safety and Efficacy of the PS Gene Editing System forMucopolysaccharidosis Type I." ASGCT 23rd Annual Meeting , pp.1-592, 2020

OU, L. Et Al. (2020) . "Long-Term Safety and Efficacy of the PS Gene Editing System forMucopolysaccharidosis Type I." ASGCT 23rd Annual Meeting , pp.1-592.

@conferencepaper{conferencepaper, author={LI OU Et Al. }, title={Long-Term Safety and Efficacy of the PS Gene Editing System forMucopolysaccharidosis Type I}, congress name={ASGCT 23rd Annual Meeting}, city={}, country={}, year={2020}, pages={1-592} }